Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 8261–8280 of 17,529 recalls

August 14, 2018· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets USP

The Issue: Undeclared Excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 14, 2018· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Diltiazem HCl Extended-release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 14, 2018· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets USP

The Issue: Undeclared Excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 14, 2018· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets USP

The Issue: Undeclared Excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 14, 2018· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets USP

The Issue: Undeclared Excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 13, 2018· Living Well Remedies, LLC

Recalled Item: Living Well Remedies Weight Away Remedy

The Issue: Microbial Contamination of Non-Sterile Products: Weight Away Remedy

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
August 13, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets USP

The Issue: Presence of Foreign Substance: Product complaint was received

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: Cyclosporine 1% Human Eye Drops

The Issue: Lack of Process Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: ADAA Cataract Drops

The Issue: Lack of Process Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: Alprostadil 500 mcg/mL Injectable

The Issue: Incorrect Product Formulation

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 10, 2018· RemedyRepack Inc.

Recalled Item: Valsartan 160 mg Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 10, 2018· RemedyRepack Inc.

Recalled Item: Valsartan 320 mg Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 10, 2018· RemedyRepack Inc.

Recalled Item: Valsartan 80 mg Tablet

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 9, 2018· Orexigen Therapeutics, Inc.

Recalled Item: Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets

The Issue: Defective Container: Customer complaints of punctures in the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 8, 2018· Akorn, Inc.

Recalled Item: Azelastine HCl Ophthalmic Solution 0.05%

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
August 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
August 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
August 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
August 7, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Diltiazem HCl Extended-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund